Market Tracker

05/25 5:15pm ET

Sangamo Therapeutics Inc (NASDAQ:SGMO)

15.60
Delayed Data
As of May 25
 -0.70 / -4.29%
Today’s Change
6.55
Today|||52-Week Range
27.50
-4.88%
Year-to-Date

Today’s Trading

Previous close16.30
Today’s open16.20
Day’s range15.50 - 16.35
Volume1,544,717
Average volume (3 months)2,388,864
Market cap$1.6B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+31.37%
Earnings growth (this year)+14.86%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)+88.60%
P/E ratioNM
Price/Sales35.02
Price/Book7.15

Competitors

----
EPZMEpizyme Inc+0.05+0.27%
FPRXFive Prime Therapeut...+0.08+0.43%
MNTAMomenta Pharmaceutic...-1.30-5.34%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateJuly 25, 2018
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$36.6M
Annual profit (last year)-$54.6M
Net profit margin-149.23%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer &
Senior Vice President
Kathy Yi
Corporate headquarters
Richmond, California

Forecasts